Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2804145

CCCCC(CCCC)=[Zr+2](C1=CC=CC1)c1cccc2c1Cc1ccccc1-2.[Cl-].[Cl-]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
DRD3 P35462 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5077609 0.92 PNMT (0.30) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL5080554 0.90 PNMT (0.30) PNMTNPC1RAB9ALMNAGAA
Hydrochloric Acid SCHEMBL5080416 0.86 PNMT (0.33) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL819427 0.84 PNMT (0.34) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL813258 0.84 PNMT (0.34) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL5081213 0.84
Hydrochloric Acid SCHEMBL216652 0.83 NPC1 (0.40) PNMTNPC1RAB9ADRD2DRD4
Hydrochloric Acid SCHEMBL5084264 0.83 AVPR2 (0.33) PNMT
Bromide SCHEMBL5079501 0.82 PNMT (0.34) PNMTNPC1RAB9A
Hydrochloric Acid SCHEMBL5080566 0.82 PNMT (0.32) PNMTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2960270-B1 BIAXIALLY STRETCHED FILM, AND ETHYLENE-TYPE POLYMER COMPOSITION PRIME POLYMER CO LTD (JP) 2017-12-20 EP disclosed
EP-2799486-B1 ETHYLENE-BASED POLYMER COMPOSITION, AND MOLDED BODY OBTAINED FROM SAME MITSUI CHEMICALS INC (JP) 2017-08-23 EP disclosed
EP-2960270-A1 BIAXIALLY STRETCHED FILM, AND ETHYLENE-TYPE POLYMER COMPOSITION Prime Polymer Co., Ltd. (JP) 2015-12-30 EP disclosed
EP-2799486-A1 ETHYLENE-BASED POLYMER COMPOSITION, AND MOLDED BODY OBTAINED FROM SAME Mitsui Chemicals, Inc. (JP) 2014-11-05 EP disclosed
US-8785574-B2 Bridged metallocene compound, olefin polymerization catalyst containing the same, and ethylene polymer obtained with the catalyst MITSUI CHEMICALS, INC. (JP) 2014-07-22 US disclosed
US-20140114031-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST PRIME POLYMER CO., LTD. (JP) 2014-04-24 US disclosed
EP-2218725-B1 BRIDGED METALLOCENE OLEFIN POLYMERIZATION CATALYST AND ETHYLENE POLYMER OBTAINED BY USING THE CATALYST MITSUI CHEMICALS INC (JP) 2013-10-23 EP disclosed
US-20100292421-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST MITSUI CHEMICALS, INC. 2010-11-18 US disclosed
EP-2218725-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND AND ETHYLENE POLYMER OBTAINED BY USING THE CATALYST Mitsui Chemicals, Inc. (JP) 2010-08-18 EP disclosed
US-7393965-B2 Crosslinked metallocene compound for olefin polymerization and method of polymerizing olefin with the same MITSUI CHEMICALS, INC. (JP) 2008-07-01 US disclosed
US-20060161013-A1 Crosslinked metallocene compound for olefin polymerization and method of polymerizing olefin with the same MITSUI CHEMICALS, INC. (JP) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161013-A1 Crosslinked metallocene compound for olefin polymerization and method of polymerizing olefin with the same PCNA, MACF1, PIN1 PNMT 153/4885NPC1 3370/4885RAB9A 4464/4885
US-20100292421-A1 BRIDGED METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE SAME, AND ETHYLENE POLYMER OBTAINED WITH THE CATALYST CAD, ENDOD1, CCT7 PNMT 1132/4885NPC1 1729/4885RAB9A 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.